Health Press Release – Weekly Newsletter for November 8-15, 2010

Gen-Probe Launches the ELUCIGENE(TM) KRAS.BRAF Kit to Detect Genetic Mutations That Help Determine Colorectal Cancer Treatment

First Single-Tube Assay to Simultaneously Detect Seven KRAS and One BRAF Mutations

MANCHESTER, England, November 8, 2010 – Gen-Probe Incorporated (Nasdaq: GPRO) has launched in Europe the
ELUCIGENE(TM) KRAS.BRAF kit, a highly sensitive, single-tube assay designed
for the simultaneous quantitative detection of seven common KRAS mutations
and the V600E BRAF mutation. The CE-marked assay provides valuable
information regarding mutation …. Read the original article  : here.

Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca(R) and Stretta(R) Systems

GREENWICH, Connecticut, November 8, 2010 – Mederi Therapeutics Inc announced today that it has received a CE Mark
authorizing the European distribution and use of Mederi's second generation
of the Stretta and Secca Systems. The Stretta System is for treatment of
gastric reflux disease, commonly known as GERD, and the Secca System is for
treatment of bowel control … Read : Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca(R) and Stretta(R) Systems.

Elsevier’s Scival(R) Spotlight(TM) Country Maps Provide a National Perspective of Interdisciplinary Research

AMSTERDAM, November 8, 2010 – Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, today announced the availability
of SciVal Spotlight country maps (www.info.scival.com). The country
maps are a new option for academic and governmental decision makers seeking
to understand national research strengths against the increasingly
interdisciplinary backdrop of global research. They are an extension …. Original source  : Elsevier's Scival(R) Spotlight(TM) Country Maps Provide a National Perspective of Interdisciplinary Research.

Scottish Medicines Consortium Approves Zebinix – Once Daily Anti-Epileptic Treatment

LONDON, November 8, 2010 – Zebinix(R) (eslicarbazepine acetate), a treatment for epilepsy, has been
accepted for restricted use in Scotland after a decision by The Scottish
Medicines Consortium (SMC).[1] Following the new clinical and cost
effectiveness decision, Zebinix can now be used as an add-on (adjunctive)
therapy in adults with partial-onset seizures, with or without secondary
generalisation (where the …. Source  : Gaea News Network.

Abbott Presents Data Exploring Relationship of Physical Function to Inflammation and Structural Damage in RA

ABBOTT PARK, Illinois, November 8, 2010 – Today, Abbott (NYSE: ABT) presents results from a pooled analysis of two
pivotal HUMIRA(R) (adalimumab) studies, which look at patients with early and
long-standing moderate to severe rheumatoid arthritis (RA), at the American
College of Rheumatology meeting in Atlanta.

The study looked at inflammation and structural damage … Read this article on Gaea Times at : Abbott Presents Data Exploring Relationship of Physical Function to Inflammation and Structural Damage in RA.

Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa

ABBOTT PARK, Illinois, November 8, 2010 – Abbott (NYSE: ABT) and the Clinton Health Access Initiative (CHAI) have
joined forces to provide HIV testing to infants in all countries working in
partnership with the CHAI. A key focus of this cooperation will be
sub-Saharan Africa, which the World Health Organization estimates to account
for 90 percent of global …. Source article on Gaea Times at  : Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa.

Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions

PARIS, November 8, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has
sent a letter to Genzyme Corporation (Nasdaq: GENZ) requesting that Genzyme
clarify its position on a number of potential Board actions raised in
Genzyme's Schedule 14D-9.

Sanofi-aventis' letter also notes that it is encouraged by Genzyme's
decision to "probe … Read the original article on Gaea Times at : Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions.

Gerresheimer Opens a Representative Office in India

Gerresheimer Steps Up Business Operations in Emerging Markets
DUSSELDORF, Germany, November 9, 2010 – Gerresheimer AG, one of the world's leading suppliers to the
pharma and healthcare industry, is still expanding its global operations. The
establishment of a representative office in Mumbai/India reflects the
company's commitment to the strategy of profiting from the consistent growth
in emerging markets.

… Read : Gerresheimer Opens a Representative Office in India.

Ziehm Imaging and Medtronic Present Interface for Image-Guided 3D Navigation

Raising Reliability Standards in the OR With Distortion-Free Intraoperative 3D Imaging

NUREMBERG, Germany, November 9, 2010 – Medical technology players Ziehm Imaging and Medtronic teamed up to
improve the use of 3D imaging together with intraoperative navigation. The
Ziehm Vision FD Vario 3D C-arm now connects to Medtronic's StealthStation(R)
navigation system over the Ziehm NaviPort interface to deliver
distortion-free …. Original article  : Ziehm Imaging and Medtronic Present Interface for Image-Guided 3D Navigation.

Shire Finalises its Acquisition of Movetis NV Following Completion of the Squeeze-Out Process

DUBLIN, November 9, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its wholly owned subsidiary Shire
Holdings Luxembourg S.??.r.l. has now acquired all of the issued shares and
warrants of Movetis NV.

Shares in Movetis NV have now been delisted from Euronext Brussels. The
last trading day was … Original article on : Shire Finalises its Acquisition of Movetis NV Following Completion of the Squeeze-Out Process.

New Assay-Ready Chemical Supply Service Launched by Peakdale and Molplex

NEWCASTLE-UPON-TYNE and CHAPEL-EN-LE-FRITH, England, November 9, 2010 – A pioneering new assay-ready, on-demand chemical supply
service has been announced today as the result of a partnership between
Molplex and Peakdale Molecular.

The new service will radically cut the cost of accessing
chemical libraries for drug discovery by providing sophisticated chemical
selection systems, allowing customers to … Read more : New Assay-Ready Chemical Supply Service Launched by Peakdale and Molplex.

International Medical News Group Launches Cardiology Product Zone in Partnership With Pure Incubation

MORRISTOWN, New Jersey, November 9, 2010 – International Medical News Group, LLC, an Elsevier company
that provides medical news and information to physicians, announced today the
launch of Cardiology Product Zone. This new product resource guide is
launched in partnership with Pure Incubation, a company that specializes in
developing data driven web properties and performance media programs that … Read the original article on Gaea Times at : International Medical News Group Launches Cardiology Product Zone in Partnership With Pure Incubation.

Elsevier Announces New Brain Research Editor-In-Chief

New Appointment Aimed at Maintaining the Ethos, Heritage and Uniqueness of This Pioneering Journal in the Field of Neuroscience

OXFORD, England, November 9, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and solutions, is pleased to announce that Dr. Irwin
B.Levitan has accepted the position of Editor-in-Chief of the journal Brain
Research. He …. Original source  : Elsevier Announces New Brain Research Editor-In-Chief.

Elsevier Supports Doctors Without Borders for Second Year Through ‘The Great Giveback’ Campaign

Percentage of Revenues From MD Consult Subscriptions Sold in Nov.-Dec. to go to Medical Relief Organization Which won the Nobel Peace Prize in 1999

PHILADELPHIA, November 9, 2010 – Elsevier, (www.elsevier.com/wps/find/homepage.cws_home)
the world-leading publisher of scientific, technical and medical information
products and services, announced today that it will contribute to Doctors
Without Borders/Medecins Sans Frontieres (MSF) (
www.doctorswithoutborders.org/) through … Original article on : Elsevier Supports Doctors Without Borders for Second Year Through 'The Great Giveback' Campaign.

Paris Pharma Events Smash All Attendance Records

Attendees up by 14%,* Exhibitor Numbers Increase to 1934.
AMSTERDAM, November 9, 2010 – Leading events organiser, UBM Live, today announced record numbers of
attendees at its flagship Pharma event, CPhI Worldwide 2010 in Paris, France.
Along with co-located events, P-MEC Europe for equipment, machinery and
technology; ICSE for contract services, clinical trials and packaging; and
BioPh for the …. Source article  : Paris Pharma Events Smash All Attendance Records.

Biggest Ever ICSE Attracts Record Attendance

AMSTERDAM, November 9, 2010 – Leading event organiser, UBM Live
(www.cmpi.biz/ubminternationalmedia), today announced that its annual
flagship pharmaceutical contract services event , ICSE Europe
(www.icsexpo.com), (Villepinte, Paris Nord 5-7 October), along with
co-located events CPhI Worldwide for pharmaceutical ingredients; P-MEC Europe
for equipment, machinery and technology and BioPh Europe for biopharma, had
attracted an increase in visitors of over 14%* …. Source article on Gaea Times at  : Biggest Ever ICSE Attracts Record Attendance.

New Drugs & Alcohol Advisory Board Established

LONDON, November 9, 2010 – A new Hair Strand Scientific Advisory Board has been
established by UK-based Trimega Laboratories. Its purpose is to analyse the
fast growing database of information created from the 10,000 hair alcohol
tests and 7,000 hair drug tests carried out in the UK each year, of which
Trimega Laboratories is responsible for around 40%.

…. Source article  : New Drugs & Alcohol Advisory Board Established.

Five-Year Market Exclusivity for VYVANSE(R) Upheld

United States Court of Appeals for the District of Columbia Circuit Reaffirms NCE Exclusivity

PHILADELPHIA, November 10, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that the U.S. Court of Appeals for the
District of Columbia Circuit has affirmed the ruling of the U.S. District
Court for the District of Columbia and … Read the original article on Gaea Times at : Five-Year Market Exclusivity for VYVANSE(R) Upheld.

Elsevier to Publish Psychosomatics: Official Journal of the Academy of Psychosomatic Medicine

Publishing Partnership to Help Advance Excellence in Consultation-Liaison Psychiatry

NEW YORK, November 10, 2010 – Elsevier, the world's leading publisher of scientific, technical and
medical information, announced today that it is partnering with the Academy
of Psychosomatic Medicine (APM) to publish Psychosomatics, the official
journal of the Academy of Psychosomatic Medicine. The announcement, made at
the annual APM meeting …. Source  : Gaea News Network.

MarketsandMarkets: Worldwide Electronic Medical Records (EMR) Market to be US$ $9,957 Million By 2015

DALLAS, November 10, 2010 – The 'Worldwide Electronic Medical Records (EMR) Market, 2010-2015
(www.marketsandmarkets.com/Market-Reports/EMR-market-253.html )
(market share, winning strategies and adoption trends)' analyzes the EMR
market by end users, components and applications and studies the major market
drivers, restraints, and opportunities for the Electronic Medical Records
market in North America, Europe, Asia and ROW.

Browse market [..] Read the original article: here.

AB Therapeutics New Anticancer Compounds Reduce by 70% Lung Tumors Growth

The Barcelona Based Biotech Company is in a Series-A Fundraising Round to Conduct Preclinical Development and to File an IND in Late 2011

BARCELONA, November 10, 2010 – The Barcelona-based biotech company AB Therapeutics has obtained high
efficacy results with its 2 new anticancer compounds in animal models of lung
cancer (NSCLC) using Membrane Lipid Therapy (MLT), … Original article on : AB Therapeutics New Anticancer Compounds Reduce by 70% Lung Tumors Growth.

UNICEF Partners With frog design for Major mHealth Initiative

frog launches 'Mobile Mandate,' a new collaboration model to drive social innovation through mobile technology

SAN FRANCISCO, November 10, 2010 – frog design today announced a collaboration with UNICEF as the
organization's lead design and innovation partner on Project Mwana, a major
mHealth initiative to improve maternal and infant health and welfare in
peri-urban Malawi and rural Zambia. … Read : UNICEF Partners With frog design for Major mHealth Initiative.

Growth in Indian Pharma Market Reflected in Expected Record Numbers for CPhI, P-MEC, ICSE and BioPh India 2010 Events

Mumbai All Set for Biggest Ever Indian Pharma Event
AMSTERDAM, November 10, 2010 – Reflecting the rapid growth in the Indian Pharma market, leading events
organiser UBM Live today announced that it expects to see a record number of
attendees at its upcoming trade events, CPhI India for pharmaceutical
ingredients and intermediates, and co-located events, P-MEC for equipment … Read this article on Gaea Times at : Growth in Indian Pharma Market Reflected in Expected Record Numbers for CPhI, P-MEC, ICSE and BioPh India 2010 Events.

IIP Recognition for Trimega Laboratories

LONDON, November 10, 2010 – UK based Trimega Laboratories is pleased to announce that it has been
recognised as having met the standards set by the prestigious Investors in
People (IIP) Standard.

Its accreditation follows an examination by the Employer Representative
Quality Board of IIP and reflects the commitment and hard work undertaken by
Trimega … Read the original article on Gaea Times at : IIP Recognition for Trimega Laboratories.

Almac’s Clinical Technologies Business Unit Again Receives ‘Best Places to Work in PA 2010′ Award

SOUDERTON, Pennsylvania, November 10, 2010 – Almac's Clinical Technologies business unit, a part of the Almac Group,
has been named one of the Best Places to Work in PA for 2010. The awards
program, created in 2000, is one of the first statewide programs of its kind
in the country. The program is a public/private partnership between … Read : Almac's Clinical Technologies Business Unit Again Receives 'Best Places to Work in PA 2010' Award.

Waters Corporation Welcomes King’s College London into Waters Centers of Innovation Program

Aim is to Support the Drug Control Centre's Efforts to Develop Novel Analytical Methods for Sports Drug Testing and Toxicological Studies

MILFORD, Massachusetts, November 10, 2010 – Waters Corporation (NYSE: WAT) today welcomed into its Centers of
Innovation Program the Drug Control Centre within the Department of Forensic
Science and Drug Monitoring at King's College London.
…. Original article on Gaea Times at  : Waters Corporation Welcomes King's College London into Waters Centers of Innovation Program.

Filtrona Porous Technologies to Display Latest Developments in Bonded Fiber and Polyurethane Foam Component Solutions at the MEDICA / COMPAMED Trade Fair

RICHMOND, Virginia, November 10, 2010 – Filtrona Porous Technologies, a custom developer and manufacturer of
medical grade foam and fiber components designed to absorb, retain, transfer,
filter or release fluids or vapors, will display an expanded range of
polyurethane foams and bonded fibers at the MEDICA / COMPAMED trade fair in
Dusseldorf, Germany from 17 to 19 November … Original source on Gaea Times at : Filtrona Porous Technologies to Display Latest Developments in Bonded Fiber and Polyurethane Foam Component Solutions at the MEDICA / COMPAMED Trade Fair.

Inaccurate Reporting on Recent Omega-3 DHA Alzheimer’s Study Reveals Misrepresentation by Media

DARTMOUTH, Nova Scotia, November 10, 2010 – Several media outlets published articles last week suggesting that
Omega-3 fish oil supplements fail to show positive results for Alzheimer's
patients. This reporting by media outlets came after the Journal of the
American Medical Association (JAMA) published the study "Docosahexaenoic Acid
Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized
Trial", where …. Source article on Gaea Times at  : Inaccurate Reporting on Recent Omega-3 DHA Alzheimer's Study Reveals Misrepresentation by Media.

Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder

ANTONY, France, November 10, 2010 – Following the announcement that Wendel had entered exclusive
negotiations with Ares Life Sciences on October 28, 2010, with a view to
selling its entire stake (around 46%) in Stallergenes, the company's Works
Council met on November 10, 2010.

Stallergenes' Works Council having returned a positive
consultative opinion at this … Original article on : Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder.

FDA Approves EGRIFTATM (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients With Lipodystrophy

Clinical Trials Demonstrate Reduction in Visceral Adipose Tissue and Waist Circumference

GENEVA, November 11, 2010 – Merck Serono, the pharmaceutical division of Merck KGaA,
Darmstadt, Germany, today announced that the U.S. Food and Drug
Administration (FDA) has approved EGRIFTA(TM) (tesamorelin for injection) as
the first and only treatment indicated to reduce excess abdominal fat in
HIV-infected patients with lipodystrophy … Read more »».

Saunders Solutions for Vets Professional Skills Online-course Suite Wins a Prestigious 2010 Brandon Hall Excellence in Learning Award

LONDON, November 11, 2010 – Elsevier's Vet CPD Professional Skills online courses have won a
coveted Brandon Hall award for excellence as 'Best Custom Content'. The suite
of five 'How To…' case-study courses build on the innovative e-learning
approach established by the trailblazing 'How to Achieve Effective
Compliance' course, created by Elsevier and its developers in conjunction
with veterinary … Read : Saunders Solutions for Vets Professional Skills Online-course Suite Wins a Prestigious 2010 Brandon Hall Excellence in Learning Award.

IndiaMART.com To Spur Indian Dental Business Through Famdent Show 2010

To Sponsor India's Leading Dental Event, Which Blends Knowledge-Sharing With Trade Exposition, for the Second Time

NEW DELHI, November 12, 2010 – Translating its objective of assisting Small and Medium
Enterprises (SMEs) in discovering new avenues and connecting with
establishments from across the globe, IndiaMART.com, India's largest online
B2B marketplace, has decided to associate with Famdent, a leading … Read the original article on Gaea Times at : IndiaMART.com To Spur Indian Dental Business Through Famdent Show 2010.

MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by 2015

DALLAS, November 12, 2010 – The 'Top 10 drug discovery technologies
(www.marketsandmarkets.com/Market-Reports/drug-discovery-41.html) -
strategic analysis and global forecasts (2010 to 2015)' analyzes the top 10
drug discovery technologies with respect to market drivers, opportunities and
trends in the diverse geographical regions including North America, Europe,
Asia and rest of the world.

Browse market data tables and … Original source on Gaea Times at : MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by 2015.